Note The "current" best practices that are detailed in this workflow were set up in 2019. Thus, they do not necessarily follow the latest best practices for scRNA-seq analysis anymore. For an ...

A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved “remarkable” improvements in patients with beta thalassaemia and sickle cell disease in an early-stage trial ...